+

WO2004048529A3 - Cell adhesion and extracellular matrix proteins - Google Patents

Cell adhesion and extracellular matrix proteins Download PDF

Info

Publication number
WO2004048529A3
WO2004048529A3 PCT/US2003/037427 US0337427W WO2004048529A3 WO 2004048529 A3 WO2004048529 A3 WO 2004048529A3 US 0337427 W US0337427 W US 0337427W WO 2004048529 A3 WO2004048529 A3 WO 2004048529A3
Authority
WO
WIPO (PCT)
Prior art keywords
extracellular matrix
cell adhesion
matrix proteins
cadecm
polynucleotides
Prior art date
Application number
PCT/US2003/037427
Other languages
French (fr)
Other versions
WO2004048529A2 (en
Inventor
April J A Hafalia
Reena Khare
Joseph P Marquis
Mili Gera
Jonathan T Wang
Anita Swarnakar
Thomas W Richardson
Shanya D Becha
Vicki S Elliott
Y Tom Tang
Preeti G Lal
Henry Yue
Craig H Ison
Narinder K Chawla
Uyen K Tran
Jennifer A Griffin
Amy E Kable
Brendan M Duggan
Ernestine A Lee
Sally Lee
Brooke M Emerling
Original Assignee
Incyte Corp
April J A Hafalia
Reena Khare
Joseph P Marquis
Mili Gera
Jonathan T Wang
Anita Swarnakar
Thomas W Richardson
Shanya D Becha
Vicki S Elliott
Y Tom Tang
Preeti G Lal
Henry Yue
Craig H Ison
Narinder K Chawla
Uyen K Tran
Jennifer A Griffin
Amy E Kable
Brendan M Duggan
Ernestine A Lee
Sally Lee
Brooke M Emerling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, April J A Hafalia, Reena Khare, Joseph P Marquis, Mili Gera, Jonathan T Wang, Anita Swarnakar, Thomas W Richardson, Shanya D Becha, Vicki S Elliott, Y Tom Tang, Preeti G Lal, Henry Yue, Craig H Ison, Narinder K Chawla, Uyen K Tran, Jennifer A Griffin, Amy E Kable, Brendan M Duggan, Ernestine A Lee, Sally Lee, Brooke M Emerling filed Critical Incyte Corp
Priority to AU2003295824A priority Critical patent/AU2003295824A1/en
Publication of WO2004048529A2 publication Critical patent/WO2004048529A2/en
Publication of WO2004048529A3 publication Critical patent/WO2004048529A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Various embodiments of the invention provide human cell adhesion and extracellular matrix proteins (CADECM) and polynucleotides which identify and encode CADECM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CADECM.
PCT/US2003/037427 2002-11-22 2003-11-20 Cell adhesion and extracellular matrix proteins WO2004048529A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003295824A AU2003295824A1 (en) 2002-11-22 2003-11-20 Cell adhesion and extracellular matrix proteins

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US42874202P 2002-11-22 2002-11-22
US60/428,742 2002-11-22
US43994703P 2003-01-13 2003-01-13
US60/439,947 2003-01-13
US44200303P 2003-01-22 2003-01-22
US44196203P 2003-01-22 2003-01-22
US60/442,003 2003-01-22
US60/441,962 2003-01-22
US45723403P 2003-03-19 2003-03-19
US60/457,234 2003-03-19

Publications (2)

Publication Number Publication Date
WO2004048529A2 WO2004048529A2 (en) 2004-06-10
WO2004048529A3 true WO2004048529A3 (en) 2005-03-17

Family

ID=32398390

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/037427 WO2004048529A2 (en) 2002-11-22 2003-11-20 Cell adhesion and extracellular matrix proteins

Country Status (2)

Country Link
AU (1) AU2003295824A1 (en)
WO (1) WO2004048529A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105117618A (en) * 2015-08-12 2015-12-02 广东顺德中山大学卡内基梅隆大学国际联合研究院 Implicated crime principle and network topological structural feature based recognition method for drug-target interaction

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535677B2 (en) 2006-06-06 2013-09-17 Oxford Biotherapeutics, Ltd. Antibody drug conjugate treatment of colorectal cancer
US7892768B2 (en) * 2007-03-02 2011-02-22 Anamar Medical Ab Diagnosis of collagen IX destruction
CN102245765B (en) 2008-10-21 2015-01-07 通用医院公司 Cell transplantation
UA108201C2 (en) 2009-04-20 2015-04-10 ANTIBODIES SPECIFIC TO CADGERINE-17
BR112013002859B1 (en) 2010-08-06 2020-10-06 The General Hospital Corporation D/B/A Massachusetts General Hospital METHOD AND APPARATUS FOR CELL TREATMENT

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5386013A (en) * 1991-01-14 1995-01-31 New York University Tumor necrosis factor-induced protein TSG-6
US5504190A (en) * 1990-11-21 1996-04-02 Torrey Pines Institute For Molecular Studies Equimolar multiple oligomer mixtures, especially oligopeptide mixtures

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504190A (en) * 1990-11-21 1996-04-02 Torrey Pines Institute For Molecular Studies Equimolar multiple oligomer mixtures, especially oligopeptide mixtures
US5386013A (en) * 1991-01-14 1995-01-31 New York University Tumor necrosis factor-induced protein TSG-6

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JANSSEN ET AL.: "Expression of inter-alpha-trypsin inhibitor and tumor necrosis factor-stimulated gene 6 in renal proximal tubular epithelial cells", KIDNEY INT., vol. 60, no. 1, July 2001 (2001-07-01), pages 126 - 136, XP002983362 *
NENTWICH ET AL.: "A novel allelic variant of the human TSG-6 gene encoding an amino acid difference in the CUB module. Chromosomal localization, frequency analysis, modeling, and expression", J BIOL CHEM, vol. 277, no. 18, 3 May 2002 (2002-05-03), pages 15354 - 15362, XP002983361 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105117618A (en) * 2015-08-12 2015-12-02 广东顺德中山大学卡内基梅隆大学国际联合研究院 Implicated crime principle and network topological structural feature based recognition method for drug-target interaction
CN105117618B (en) * 2015-08-12 2018-01-26 广东顺德中山大学卡内基梅隆大学国际联合研究院 A Drug-Target Interaction Identification Method Based on the Principle of Implications and Network Topological Structure Features

Also Published As

Publication number Publication date
AU2003295824A8 (en) 2004-06-18
WO2004048529A2 (en) 2004-06-10
AU2003295824A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
WO2002002634A3 (en) Human extracellular matrix and cell adhesion polypeptides
WO2003104410A3 (en) Enzymes
WO2003047526A3 (en) Cell adhesion and extracellular matrix proteins
WO2004044165A3 (en) Lipid-associated proteins
WO2004048550A3 (en) Immune response associated proteins
WO2003068943A3 (en) Secreted proteins
WO2003063688A3 (en) Protein modification and maintenance molecules
WO2004048529A3 (en) Cell adhesion and extracellular matrix proteins
WO2001042285A3 (en) Extracellular matrix and cell adhesion proteins as well as genes encoding them
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2003077875A3 (en) Proteins associated with growth, differentiation, and death
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2004015396A3 (en) Cell adhesion and extracellular matrix proteins
WO2003094843A3 (en) Cell adhesion and extracellular matrix proteins
WO2004003162A3 (en) Enzymes
WO2002088322A3 (en) Cell adhesion and extracellular matrix proteins
WO2004031364A3 (en) Proteins associated with cell growth, differentiation, and death
WO2003087300A3 (en) Secreted proteins
WO2004094623A3 (en) Cell adhesion and extracellular matrix proteins
WO2003072729A3 (en) Enzymes
WO2003095622A3 (en) Proteins associated with cell growth, differentiation, and death
WO2003027230A3 (en) Cell adhesion and extracellular matrix proteins
WO2003093439A3 (en) Enzymes
WO2003083082A3 (en) Enzymes
WO2004022705A3 (en) Neurotransmission-associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载